U.S., April 3 -- ClinicalTrials.gov registry received information related to the study (NCT06905886) titled 'Resting Energy Expenditure in Postmenopausal Women' on March 31.
Brief Summary: Obesity and its associated comorbidities are rising at an alarming rate, particularly among postmenopausal women. Menopause, characterized by a decline in estradiol and progesterone levels, is often accompanied by weight gain. Fear of this weight gain is a major reason why many women hesitate to initiate or continue menopausal hormone therapy (MHT), with discontinuation often occurring within the first few months. However, scientific evidence on whether MHT influences weight gain remains inconclusive. A Cochrane Review found no significant effect of estr...